Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/14/25 16:30 | 3/12/25 | RPTX | Health | Drug | Pharmaceutical Preparations | Koehler Maria | A8 | O | EVP,CHIE | 3 | S.m | -15 | 2.51 | 0 | -6 | 232 | D | |||||||||||||||
3/14/25 16:30 | 3/12/25 | RPTX | Health | Drug | Pharmaceutical Preparations | Zinda Michael | A8 | O | EVP,CHIE | 3 | S.m | -17 | 2.14 | 0 | -8 | 80 | D | |||||||||||||||
3/14/25 16:30 | 3/12/25 | RPTX | Health | Drug | Pharmaceutical Preparations | Forte Steve | A8 | O | EVP,CFO | 3 | S.m | -27 | 2.45 | 0 | -11 | 55 | D | |||||||||||||||
3/14/25 16:30 | 3/12/25 | RPTX | Health | Drug | Pharmaceutical Preparations | Segal Lloyd Mitchell | A8 | DO | P,CEO | 3 | S.m | -85 | 2.49 | 0 | -34 | 232 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |